Safety Profile and Clinical Activity of Multiple Subcutaneous Doses of MEDI-528, a Humanized Anti-Interleukin-9 Monoclonal Antibody, in Two Randomized Phase 2a Studies in Subjects With Asthma

BMC Pulmonary Medicine - United Kingdom
doi 10.1186/1471-2466-11-14